BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fayek SA, Quintini C, Chavin KD, Marsh CL. The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council. Am J Transplant 2016;16:3093-104. [PMID: 27545282 DOI: 10.1111/ajt.14017] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Lopez-Lopez V, Ruiz-Manzanera JJ, Eshmuminov D, Lehmann K, Schneider M, von der Groeben M, de Angulo DR, Gajownik U, Pons JA, Sanchez-Bueno F, Robles-Campos R, Ramirez-Romero P. Are We Ready for Bariatric Surgery in a Liver Transplant Program? Obes Surg. 2020;31:1214-1222. [PMID: 33225408 DOI: 10.1007/s11695-020-05118-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cullaro G, Verna EC, Lee BP, Lai JC. Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes. Liver Transpl. 2020;26:498-506. [PMID: 31785069 DOI: 10.1002/lt.25694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
3 Gallardo-Flores CE, Colpitts CC. Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches. Pathogens 2021;10:902. [PMID: 34358052 DOI: 10.3390/pathogens10070902] [Reference Citation Analysis]
4 Nagai S, Suzuki Y, Kitajima T, Ivanics T, Shimada S, Kuno Y, Shamaa MT, Yeddula S, Samaniego M, Collins K, Rizzari M, Yoshida A, Abouljoud M. Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver-Kidney Allocation Policy. Liver Transpl 2021. [PMID: 34043869 DOI: 10.1002/lt.26107] [Reference Citation Analysis]
5 Molinari M, Ayloo S, Tsung A, Jorgensen D, Tevar A, Rahman SH, Jonassaint N. Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations. Transplantation 2019;103:e297-307. [PMID: 31283673 DOI: 10.1097/TP.0000000000002810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
6 Ogura Y, Kabacam G, Singhal A, Moon DB. The role of living donor liver transplantation for acute liver failure. Int J Surg 2020;82S:145-8. [PMID: 32353557 DOI: 10.1016/j.ijsu.2020.04.058] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wadei HM, Burcin Taner C, Keaveny AP, Mai ML, Hodge DO, White LJ, Harnois DM, Mao SA, Jarmi T, Croome KP. The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center. Ann Hepatol 2021;24:100317. [PMID: 33545403 DOI: 10.1016/j.aohep.2021.100317] [Reference Citation Analysis]
8 Choudhury RA, Prins K, Moore HB, Yoeli D, Kam A, Nydam TL. Uncontrolled deceased cardiac donation: An unutilized source for organ transplantation in the United States. Clin Transplant 2019;33:e13474. [PMID: 30597670 DOI: 10.1111/ctr.13474] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Silverstein J, Roll G, Dodge JL, Grab JD, Yao FY, Mehta N. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients. Liver Transpl 2020;26:1100-11. [PMID: 32531867 DOI: 10.1002/lt.25819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Kanjanahattakij N, Lapumnuaypol K, Fatima S, Feyssa E. Gallstone Pancreatitis: A Common but Often Overlooked Cause of Abdominal Pain in Post-Liver-Transplant Patients. Case Rep Transplant 2017;2017:6047046. [PMID: 29201486 DOI: 10.1155/2017/6047046] [Reference Citation Analysis]
11 Wiering L, Sponholz F, Brandl A, Dziodzio T, Jara M, Dargie R, Eurich D, Schmelzle M, Sauer IM, Aigner F, Kotsch K, Pratschke J, Öllinger R, Ritschl PV. Perioperative Pleural Drainage in Liver Transplantation: A Retrospective Analysis from a High-Volume Liver Transplant Center. Ann Transplant 2020;25:e918456. [PMID: 31949125 DOI: 10.12659/AOT.918456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wong RJ, Robinson A, Ginzberg D, Gomes C, Liu B, Bhuket T. Assessing the safety of beta-blocker therapy in cirrhosis patients with ascites: A meta-analysis. Liver Int 2019;39:1080-8. [PMID: 30614656 DOI: 10.1111/liv.14040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
13 German MN, Eccleston JL, Tamez DA, Remington PL, Lucey MR. Internet Published Policies Regarding Liver Transplant Eligibility and Substance Use in United States Transplant Centers. Hepatol Commun 2020;4:1717-24. [PMID: 33163840 DOI: 10.1002/hep4.1591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khemka A, Rao RA, Ghumman W, Mahenthiran J, Feigenbaum H, Sawada SG. Safety and feasibility of dopamine-atropine stress echocardiography. Echocardiography 2021;38:568-73. [PMID: 33675266 DOI: 10.1111/echo.15020] [Reference Citation Analysis]
15 Weinberg EM, Curry MP, Frenette CT, Regenstein FG, Schiff ER, Goodman ZD, Robinson JM, Chan JL, Imperial JC, Reddy KR. Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis. Liver Transpl 2021;27:568-79. [PMID: 33164276 DOI: 10.1002/lt.25934] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Yu DD, Van Citters G, Li H, Stoltz BM, Forman BM. Discovery of novel modulators for the PPARα (peroxisome proliferator activated receptor α): Potential therapies for nonalcoholic fatty liver disease. Bioorg Med Chem 2021;41:116193. [PMID: 34022528 DOI: 10.1016/j.bmc.2021.116193] [Reference Citation Analysis]
17 MacConmara M, Vagefi PA. Machine Perfusion in Liver Transplantation. Adv Surg 2021;55:175-95. [PMID: 34389091 DOI: 10.1016/j.yasu.2021.05.013] [Reference Citation Analysis]
18 Cai W, Fan Y, Hu H, Xiang N, Fang C, Jia F. Postoperative liver volume was accurately predicted by a medical image three dimensional visualization system in hepatectomy for liver cancer. Surg Oncol. 2017;26:188-194. [PMID: 28577725 DOI: 10.1016/j.suronc.2017.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
19 Bunnapradist S, Danovitch GM. Marginal quality kidneys for simultaneous liver-kidney transplantation: To pass or double down? Liver Transpl 2017;23:7-8. [PMID: 27805302 DOI: 10.1002/lt.24669] [Reference Citation Analysis]
20 Schaffhausen CR, Bruin MJ, Chu S, Fu H, McKinney WT, Schladt D, Snyder JJ, Kim WR, Lake JR, Kasiske BL, Israni AK. Tool to Aid Patients in Selecting a Liver Transplant Center. Liver Transpl 2020;26:337-48. [PMID: 31923342 DOI: 10.1002/lt.25715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Garcia JHP, Lima AS, Coelho JCU, Bittencourt PL, Alves VAF, D'Albuquerque LAC, Carrilho FJ; Brazilian HCC Study Group. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Ann Hepatol 2021;22:100294. [PMID: 33276136 DOI: 10.1016/j.aohep.2020.100294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, Terai S. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regen. 2017;37:16. [PMID: 29259715 DOI: 10.1186/s41232-017-0045-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 9.8] [Reference Citation Analysis]
23 Yang Z, Gerull WD, Shepherd HM, Marklin GF, Takahashi T, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Pasque MK, Yan Y, Kreisel D, Puri V. Different-team procurements: A potential solution for the unintended consequences of change in lung allocation policy. Am J Transplant 2021;21:3101-11. [PMID: 33638937 DOI: 10.1111/ajt.16553] [Reference Citation Analysis]
24 Sigireddi RR, Carrion AF. Improving Access to Liver Transplantation through the ECHO Telehealth Model. Tex Heart Inst J 2019;46:61-2. [PMID: 30833844 DOI: 10.14503/THIJ-18-6738] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kazemi K, Nikeghbalian Z, Yaghmaei S, Nikeghbalian S, Shamsaeifar A, Asgharnia Y, Dehghankhalili M, Golchini A, Malekhosseini SA. University of Wisconsin vs normal saline solutions for preservation of blood vessels of brain dead donors: A histopathological study. Clin Transplant 2018;32:e13241. [PMID: 29573462 DOI: 10.1111/ctr.13241] [Reference Citation Analysis]
26 Karunungan KL, Sanaiha Y, Hernandez RA, Wilhalme H, Rudasill S, Hadaya J, DiNorcia J, Benharash P. Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States. Liver Transpl 2021;27:200-8. [PMID: 33185336 DOI: 10.1002/lt.25936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Kirchner VA, Goldaracena N, Sapisochin G, Alejandro RH, Shah SA. Current status of liver transplantation in North America. Int J Surg 2020;82S:9-13. [PMID: 32473238 DOI: 10.1016/j.ijsu.2020.05.059] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kwong AJ, Kim WR, Flemming JA. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology. 2018;68:1288-1297. [PMID: 29672886 DOI: 10.1002/hep.30045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kwong AJ, Flores A, Saracino G, Boutté J, Mckenna G, Testa G, Bahirwani R, Wall A, Kim WR, Klintmalm G, Trotter JF, Asrani SK. Center Variation in Intention‐to‐Treat Survival Among Patients Listed for Liver Transplant. Liver Transpl 2020;26:1582-93. [DOI: 10.1002/lt.25852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Effenberger M, Kronbichler A, Bettac E, Grabherr F, Grander C, Adolph TE, Mayer G, Zoller H, Perco P, Tilg H. Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. J Med Internet Res 2021;23:e21656. [PMID: 34402801 DOI: 10.2196/21656] [Reference Citation Analysis]
31 Nejatollahi SMR, Marashi SA, Janatmakan F, Vosoghian M, Hasanzadehkiabi M, Fazel I. A Single-Center Report on Liver Transplantation: First Experiences from Shahid Beheshti University of Medical Sciences. Middle East J Dig Dis 2020;12:252-6. [PMID: 33564382 DOI: 10.34172/mejdd.2020.190] [Reference Citation Analysis]
32 Fukazawa K, Pretto EA, Nishida S, Reyes JD, Gologorsky E. Factors associated with mortality within 24 h of liver transplantation: An updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013. Journal of Clinical Anesthesia 2018;44:35-40. [DOI: 10.1016/j.jclinane.2017.10.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
33 Labgaa I, Tabrizian P, Titano J, Kim E, Thung SN, Florman S, Schwartz M, Melloul E. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma. HPB 2019;21:1497-504. [DOI: 10.1016/j.hpb.2019.03.360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
34 Ge J, Lai JC. Split‐Liver Allocation: An Underused Opportunity to Expand Access to Liver Transplantation. Liver Transpl 2019;25:690-1. [DOI: 10.1002/lt.25458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Quintini C, Liu Q. Disrupting the Field of Organ Preservation: Normothermic Preservation in Liver Transplantation. Transplantation 2018;102:1783-5. [PMID: 30346373 DOI: 10.1097/TP.0000000000002410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Gong N, Jia C, Huang H, Liu J, Huang X, Wan Q. Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death. Ann Transplant 2020;25:e926020. [PMID: 33273447 DOI: 10.12659/AOT.926020] [Reference Citation Analysis]
37 Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int. 2019;39:788-801. [PMID: 30843314 DOI: 10.1111/liv.14091] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 22.0] [Reference Citation Analysis]
38 Slaughter VL, Rumsey JW, Boone R, Malik D, Cai Y, Sriram NN, Long CJ, McAleer CW, Lambert S, Shuler ML, Hickman JJ. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Sci Rep 2021;11:13159. [PMID: 34162924 DOI: 10.1038/s41598-021-92264-2] [Reference Citation Analysis]
39 Wang S, Toy M, Hang Pham TT, So S. Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. PLoS One 2020;15:e0239393. [PMID: 32946502 DOI: 10.1371/journal.pone.0239393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Ito T, Naini BV, Markovic D, Aziz A, Younan S, Lu M, Hirao H, Kadono K, Kojima H, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am J Transplant 2021;21:614-25. [PMID: 32713098 DOI: 10.1111/ajt.16219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
41 Nascimento GF, Gomes RM, Alvares-Teodoro J, Ribeiro NG, Cherchiglia ML, Simão-Filho C, Acurcio FA, Sarmento TTR, Gargano LP, Guerra AA. Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies. Front Pharmacol 2020;11:572043. [PMID: 33123009 DOI: 10.3389/fphar.2020.572043] [Reference Citation Analysis]
42 Quintini C, Martins PN, Shah S, Killackey M, Reed A, Guarrera J, Axelrod DA; for the American Society of Transplant Surgeons Standards Committee. Implementing an innovated preservation technology: The American Society of Transplant Surgeons’ (ASTS) Standards Committee White Paper on Ex Situ Liver Machine Perfusion. Am J Transplant 2018;18:1865-74. [DOI: 10.1111/ajt.14945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
43 Kishore SA, Bajwa R, Madoff DC. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers (Basel) 2020;12:E791. [PMID: 32224882 DOI: 10.3390/cancers12040791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
44 Jia JJ, Li JH, Yu H, Nie Y, Jiang L, Li HY, Zhou L, Zheng SS. Machine perfusion for liver transplantation: A concise review of clinical trials. Hepatobiliary Pancreat Dis Int. 2018;17:387-391. [PMID: 30352672 DOI: 10.1016/j.hbpd.2018.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, Washburn K, Pawlik TM. Early mortality after liver transplantation: Defining the course and the cause. Surgery 2018;164:694-704. [DOI: 10.1016/j.surg.2018.04.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
46 Yang N, Du Y, He J, Ge J, Wang M, Sun R, Zhu H, Ge W. Distribution evaluation of tacrolimus in the ascitic fluid of liver transplant recipients with liver cirrhosis by a sensitive ultra-performance liquid chromatography-tandem mass spectrometry method. J Sep Sci 2021. [PMID: 34694679 DOI: 10.1002/jssc.202100714] [Reference Citation Analysis]
47 Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol 2017;67:517-25. [PMID: 28483678 DOI: 10.1016/j.jhep.2017.04.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
48 de Miguel-Yanes JM, Jiménez-García R, de Miguel-Díez J, Hernández-Barrera V, Méndez-Bailón M, Muñoz-Rivas N, López-de-Andrés A. In-hospital outcomes for solid organ transplants according to type 2 diabetes status: An observational, 15-year study in Spain. Int J Clin Pract 2018;:e13283. [PMID: 30317700 DOI: 10.1111/ijcp.13283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Chiang HW, Chuang TC, Chen CL, Tyan YS, Lin TL, Tsang LL, Tu JA, Chou YH, Tsai HY, Chen TR. Effective dose for multiple and repeated radiation examinations in donors and recipients of adult-to-adult living donor liver transplants at a single center. Eur J Radiol 2020;129:109078. [PMID: 32447148 DOI: 10.1016/j.ejrad.2020.109078] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Czigany Z, Craigie EC, Lurje G, Song S, Yonezawa K, Yamamoto Y, Minor T, Tolba RH. Adenosine A2a Receptor Stimulation Attenuates Ischemia-Reperfusion Injury and Improves Survival in A Porcine Model of DCD Liver Transplantation. Int J Mol Sci 2020;21:E6747. [PMID: 32938013 DOI: 10.3390/ijms21186747] [Reference Citation Analysis]
51 Poordad F, Castro RE, Asatryan A, Aguilar H, Cacoub P, Dieterich D, Marinho RT, Carvalho A, Siddique A, Hu YB, Charafeddine M, Bondin M, Khan N, Cohen DE, Felizarta F. Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials. J Viral Hepat 2020;27:497-504. [PMID: 31954087 DOI: 10.1111/jvh.13261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Morales MK, Lambing T, Husson J. Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate. Curr Treat Options Infect Dis 2020;12:87-111. [DOI: 10.1007/s40506-020-00220-x] [Reference Citation Analysis]
53 Agasthi P, Buras MR, Smith SD, Golafshar MA, Mookadam F, Anand S, Rosenthal JL, Hardaway BW, Devaleria P, Arsanjani R. Machine learning helps predict long-term mortality and graft failure in patients undergoing heart transplant. Gen Thorac Cardiovasc Surg 2020;68:1369-76. [DOI: 10.1007/s11748-020-01375-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ripoll JG, Wanta BT, Wetzel DR, Frank RD, Findlay JY, Vogt MNP. Association of Perioperative Variables and the Acute Respiratory Distress Syndrome in Liver Transplant Recipients. Transplant Direct 2020;6:e520. [PMID: 32047848 DOI: 10.1097/TXD.0000000000000965] [Reference Citation Analysis]